表紙
市場調査レポート

日本の呼吸器系疾患市場:市場展望と新たな機会

Japan Respiratory Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

発行 Venture Planning Group 商品コード 261610
出版日 ページ情報 英文 282 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。

Local License: 同一事業所内

Back to Top
日本の呼吸器系疾患市場:市場展望と新たな機会 Japan Respiratory Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
出版日: ページ情報: 英文 282 Pages
概要

当レポートでは、日本における呼吸器系疾患の関連市場について分析し、研究開発の最新動向と将来展望、今後の市場動向の予測(主要サプライヤーの市場収益・シェアなど)、市場のリスク、主な製品開発機会、主要企業のプロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界の市場・技術の概要

  • 主な感染症の検査(背景事情、診断検査、ワクチン・薬剤など)
    • アデノウイルス
    • インフルエンザウイルス
    • レジオネラ
    • 単核球症
    • マイコプラズマ
    • 肺炎
    • 呼吸系発疹ウイルス(RSV)
    • 結核症
  • 代表的な解析装置のレビュー(発売元:Abbott、Beckman Coulter/Danaher、BioMerieux、Ortho-Clinical Diagnostics、Roche、Siemens、東ソー、Wallacほか)
  • 新規の診断技術
    • 分子診断
    • モノクローナル抗体
    • 免疫学的検定
    • 差分光散乱
    • 情報技術(IT)
    • 人工知能
    • リポソーム
    • フローサイトメトリ
    • クロマトグラフィ
    • 画像診断
    • ゲル微液滴
    • その他

日本市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

主要製品の開発機会

  • 検査装置
  • 試薬キットおよび検査システム/パネル
  • IT(情報技術)
  • 付属品

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者の主な種類
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業分析

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher
  • Wallac
  • 和光純薬工業

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPID20348

About This Report

This new 282-page report from VPGMarketResearch.com presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs.    

In addition to market share and sales forecasts, the report:

-  Examines market applications of Molecular Diagnostics,  
   Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

-  Reviews features and operating characteristics of major analyzers used 
   for microbiology testing;

-  Profiles key suppliers and potential market entrants developing innovative
   technologies and products; and

-  Analyzes emerging opportunities, alternative market penetration strategies, 
   market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.

Contains 282  pages and 22 tables

Table of Contents

Introduction

Worldwide Market and Technology Overview

  • A. Major Infectious Disease Tests
    • 1. Adenovirus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
      • d. Adeno-Associated Viruses(AAV)
    • 2. Influenza Viruses
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 3. Legionella
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 4. Mononucleosis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 5. Mycoplasma
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 6. Pneumonia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 7. Respiratory Syncytial Virus (RSV)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 8. Tuberculosis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
  • B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares

Major Product Development Opportunities

  • A. Instrumentation
  • B. Reagent Kits and Test Systems/panels
  • C. Information Technology
  • D. Auxiliary Products

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac
  • Wako

List of Tables

  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Tuberculosis Tests
  • Japan
  • Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Legionella Testing Market Diagnostics Sales Forecast by Major Supplier
  • Japan
  • Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Mononucleosis Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Mycoplasma Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Pneumonia Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • RSV Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • RSV Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Tuberculosis Testing Market Diagnostics Sales by Major Supplier
Back to Top